Table V.
Univariate Cox regression | Multivariate Cox regression | |||||
---|---|---|---|---|---|---|
Variables | P-value | HR | 95% CI | P-value | HR | 95% CI |
Risk score (high/low) | 0.003a | 4.949 | 1.735–14.117 | 0.001a | 3.393 | 1.597–7.210 |
Age (>60/≤60) | 0.202 | 1.816 | 0.726–4.543 | |||
BMI | 0.060 | |||||
<25 | Reference | |||||
≥25 | 0.245 | 0.073–0.818 | ||||
Not reported | 0.779 | 0.096–6.340 | ||||
Race | 0.423 | |||||
Non-Asian | Reference | |||||
Asian | 0.352 | 0.053–2.322 | ||||
Not reported | 1.915 | 0.115–31.769 | ||||
Sex (Male/Female) | 0.143 | 2.590 | 0.725–9.251 | |||
Hepatitis B or C | 0.542 | |||||
No | Reference | |||||
Yes | 1.489 | 0.415–5.346 | ||||
Cirrhosis | 0.216 | |||||
Non-cirrhosis | Reference | |||||
Cirrhosis | 3.183 | 0.524–19.324 | ||||
Not reported | 0.572 | 0.178–1.843 | ||||
Histologic grade | 0.586 | |||||
G1-2 | Reference | |||||
G3-4 | 1.326 | 0.481–3.649 | ||||
New tumor event | 0.406 | |||||
No | Reference | |||||
Yes | 1.126 | 0.216–5.883 | ||||
Not reported | 16.771 | 0.260–1080.40 | ||||
Pathologic stage | 0.093 | |||||
Stage I+II | Reference | |||||
Stage III+IV | 2.857 | 0.935–8.730 | ||||
Not reported | 3.173 | 0.740–13.617 | ||||
Cancer status | 0.998 | |||||
Tumor free | Reference | |||||
With tumor | 1.052 | 0.196–5.635 | ||||
Not reported | 0.000 | 0.000 | ||||
Family cancer history | 0.031 | 0.126 | ||||
No | Reference | Reference | ||||
Yes | 0.667 | 0.234–1.899 | 0.868 | 0.419–1.799 | ||
Not reported | 0.076 | 0.011–0.528 | 0.206 | 0.045–0.953 | ||
Residual tumor | 0.611 | |||||
R0 | Reference | |||||
Non-R0 | 0.469 | 0.105–2.092 | ||||
Not reported | 0.000 | 0.000 | ||||
Vascular invasion | 0.006a | 0.005a | ||||
Negative | Reference | Reference | ||||
Positive | 3.019 | 0.798–11.416 | 2.146 | 0.903–5.104 | ||
Not reported | 8.383 | 2.264–31.038 | 3.577 | 1.652–7.748 |
P<0.05. BMI, Body mass index; AFP, α fetoprotein; HR, Hazard ratio; CI, Confidence interval.